reserpine has been researched along with tetracycline in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 8 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elkins, CA; Mullis, LB | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chérigo, L; Fragoso-Serrano, M; Gibbons, S; Jacobo-Herrera, N; Kaatz, GW; Pereda-Miranda, R | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carlton, WW; McCracken, MD; Tuite, J | 1 |
| Lüllmann, H; Schaefer, J | 1 |
| Gibbons, S; Udo, EE | 1 |
| LESPAGNOL, A; LESPAGNOL, C | 1 |
| SCANLON, RT | 1 |
| Jurado, A; Marco, F; Ribera, A; Ruiz, J; Vila, J | 1 |
| Aínsa, JA; De Rossi, E; Martín, C; Ramón-García, S | 1 |
| Bishai, WR; Grosset, JH; Nuermberger, EL; Zhang, T | 1 |
| Dey, D; Ghosh, S; Hazra, B; Ray, R | 1 |
1 review(s) available for reserpine and tetracycline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
19 other study(ies) available for reserpine and tetracycline
| Article | Year |
|---|---|
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Binding, Competitive; Carrier Proteins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Indicators and Reagents; Microbial Sensitivity Tests; Progesterone; Steroids | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Inhibitors of bacterial multidrug efflux pumps from the resin glycosides of Ipomoea murucoides.
Topics: Anti-Bacterial Agents; Carbohydrate Sequence; Chromatography, High Pressure Liquid; Drug Resistance, Multiple, Bacterial; Fatty Acids; Glycosides; Ipomoea; Membrane Transport Proteins; Mexico; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plants, Medicinal; Resins, Plant; Staphylococcus aureus | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Drugs in breast milk.
Topics: Anticoagulants; Anticonvulsants; Antineoplastic Agents; Antithyroid Agents; Aspirin; Atropine; Caffeine; Chloramphenicol; Chlorothiazide; Contraceptives, Oral; Ergot Alkaloids; Ethanol; Female; Humans; Hypnotics and Sedatives; Methadone; Milk, Human; Nalidixic Acid; Narcotics; Penicillins; Quinine; Reserpine; Sulfonamides; Tetracycline | 1974 |
Penicillium viridicatum mycotoxicosis in the rat. IV. Attempts to modify the tissue responses.
Topics: Animals; Body Weight; Castration; Cornea; Diet; Eye; Kidney; Liver; Male; Mycotoxins; Necrosis; Penicillium; Prednisolone; Rats; Reserpine; Scrotum; Skin; Stomach; Tetracycline; Time Factors; Tripelennamine | 1974 |
[Acute left heart failure, pulmonary edema].
Topics: Acute Disease; Aged; Furosemide; Heart Failure; Humans; Lanatosides; Male; Morphine; Oxygen Inhalation Therapy; Pulmonary Edema; Reserpine; Tetracycline | 1973 |
The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(K) determinant.
Topics: Anti-Bacterial Agents; Antihypertensive Agents; Bacterial Proteins; DNA Primers; Membrane Proteins; Methicillin Resistance; Microbial Sensitivity Tests; Polymerase Chain Reaction; Reserpine; Staphylococcus aureus; Tetracycline; Tetracycline Resistance | 2000 |
[RECENT THERAPEUTIC ACQUISITIONS DUE TO CHEMICAL SYNTHESIS].
Topics: Adrenal Cortex Hormones; Aldosterone; Anabolic Agents; Anesthetics; Anesthetics, Local; Anti-Bacterial Agents; Cortisone; Ergot Alkaloids; Estrogens; Indoles; Lysergic Acid Diethylamide; Oxytocics; Oxytocin; Penicillins; Progestins; Reserpine; Steroids; Tetracycline | 1963 |
PLACENTAL TRANSMISSION OF DRUGS.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Anti-Bacterial Agents; Barbiturates; Chloramphenicol; Demeclocycline; Female; Fetal Diseases; Humans; Infant, Newborn; Maternal-Fetal Exchange; Meperidine; Oxytetracycline; Pregnancy; Progesterone; Reserpine; Streptomycin; Sulfisoxazole; Tetracycline; Thiouracil; Thyroxine; Toxicology; Vitamin K | 1964 |
Evidence for a reserpine-affected mechanism of resistance to tetracycline in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Gonorrhea; Humans; Neisseria gonorrhoeae; Reserpine; Tetracycline; Tetracycline Resistance | 2005 |
Characterization of tetracycline resistance mediated by the efflux pump Tap from Mycobacterium fortuitum.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlorpromazine; Drug Synergism; Electrochemistry; Energy Metabolism; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium fortuitum; Reserpine; Solvents; Tetracycline; Tetracycline Resistance; Uncoupling Agents; Vanadates | 2006 |
Rapid assessment of antibacterial activity against Mycobacterium ulcerans by using recombinant luminescent strains.
Topics: Anti-Bacterial Agents; Erythromycin; Luminescent Proteins; Microbial Sensitivity Tests; Models, Genetic; Mycobacterium ulcerans; Reserpine; Tetracycline | 2010 |
Polyphenolic Secondary Metabolites Synergize the Activity of Commercial Antibiotics against Clinical Isolates of β-Lactamase-producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Caffeic Acids; Catechin; Ciprofloxacin; Drug Synergism; Ellagic Acid; Gentamicins; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phytochemicals; Polyphenols; Quercetin; Reserpine; Tetracycline | 2016 |